Literature DB >> 25625698

Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages.

Carlos Cabral1, Pedro M Morgado2, Durval Campos Costa3, Margarida Silveira4.   

Abstract

Early diagnosis of Alzheimer disease (AD), while still at the stage known as mild cognitive impairment (MCI), is important for the development of new treatments. However, brain degeneration in MCI evolves with time and differs from patient to patient, making early diagnosis a very challenging task. Despite these difficulties, many machine learning techniques have already been used for the diagnosis of MCI and for predicting MCI to AD conversion, but the MCI group used in previous works is usually very heterogeneous containing subjects at different stages. The goal of this paper is to investigate how the disease stage impacts on the ability of machine learning methodologies to predict conversion. After identifying the converters and estimating the time of conversion (TC) (using neuropsychological test scores), we devised 5 subgroups of MCI converters (MCI-C) based on their temporal distance to the conversion instant (0, 6, 12, 18 and 24 months before conversion). Next, we used the FDG-PET images of these subgroups and trained classifiers to distinguish between the MCI-C at different stages and stable non-converters (MCI-NC). Our results show that MCI to AD conversion can be predicted as early as 24 months prior to conversion and that the discriminative power of the machine learning methods decreases with the increasing temporal distance to the TC, as expected. These findings were consistent for all the tested classifiers. Our results also show that this decrease arises from a reduction in the information contained in the regions used for classification and by a decrease in the stability of the automatic selection procedure.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer׳s disease; Conversion; Early diagnosis; FDG-PET; Machine learning; Mild cognitive impairment

Mesh:

Year:  2015        PMID: 25625698     DOI: 10.1016/j.compbiomed.2015.01.003

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  22 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

Review 3.  A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.

Authors:  Silvia Morbelli; Valentina Garibotto; Elsmarieke Van De Giessen; Javier Arbizu; Gaël Chételat; Alexander Drezgza; Swen Hesse; Adriaan A Lammertsma; Ian Law; Sabina Pappata'; Pierre Payoux; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09       Impact factor: 9.236

Review 4.  A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.

Authors:  Saima Rathore; Mohamad Habes; Muhammad Aksam Iftikhar; Amanda Shacklett; Christos Davatzikos
Journal:  Neuroimage       Date:  2017-04-13       Impact factor: 6.556

5.  A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment.

Authors:  Min Wang; Zhuangzhi Yan; Shu-Yun Xiao; Chuantao Zuo; Jiehui Jiang
Journal:  Behav Neurol       Date:  2020-08-18       Impact factor: 3.342

6.  Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.

Authors:  Fabrizio De Carli; Flavio Nobili; Marco Pagani; Matteo Bauckneht; Federico Massa; Matteo Grazzini; Cathrine Jonsson; Enrico Peira; Silvia Morbelli; Dario Arnaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-31       Impact factor: 9.236

7.  Alzheimer's disease diagnosis based on the Hippocampal Unified Multi-Atlas Network (HUMAN) algorithm.

Authors:  Nicola Amoroso; Marianna La Rocca; Roberto Bellotti; Annarita Fanizzi; Alfonso Monaco; Sabina Tangaro
Journal:  Biomed Eng Online       Date:  2018-01-22       Impact factor: 2.819

8.  Histogram-Based Features Selection and Volume of Interest Ranking for Brain PET Image Classification.

Authors:  Imene Garali; Mouloud Adel; Salah Bourennane; Eric Guedj
Journal:  IEEE J Transl Eng Health Med       Date:  2018-03-16       Impact factor: 3.316

9.  Genome-wide association study identifies RBFOX1 locus influencing brain glucose metabolism.

Authors:  Ling-Li Kong; Dan Miao; Lin Tan; Shu-Lei Liu; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-11

10.  Predicting progression of mild cognitive impairment to dementia using neuropsychological data: a supervised learning approach using time windows.

Authors:  Telma Pereira; Luís Lemos; Sandra Cardoso; Dina Silva; Ana Rodrigues; Isabel Santana; Alexandre de Mendonça; Manuela Guerreiro; Sara C Madeira
Journal:  BMC Med Inform Decis Mak       Date:  2017-07-19       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.